Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Evoq Remedies Ltd

Your Vote -

Buy

25.00%

Hold

25.00%

Sell

50.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Evoq Remedies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Evoq Remedies - Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal

    11 Jun 2026, 5:16PM Corporate Insolvency Resolution Process (CIRP) - Admission of application by Tribunal
  • Evoq Remedies - Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal

    10 Jun 2026, 6:11PM Corporate Insolvency Resolution process (CIRP) - Admission of application by Tribunal
  • Evoq Remedies - Integrated Filing (Finance) For The Half Year And Year Ended On 31St March, 2026

    30 May 2026, 7:44PM Submission of Integrated Financial Results for the Half year and Year ended on 31st March, 2026
  • Evoq Remedies - Appointment Of M/S. Jay Pandya & Associates (FRN: S2024GJ963300), Company Secretaries, Ahmedabad, As Secretar

    30 May 2026, 7:42PM Appointment of Secretarial Auditor of the Company for FY 2025-26.
  • Evoq Remedies - Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March, 2026 Along With Audit

    30 May 2026, 7:37PM Board of Directors has approved Audited Financials results for the Halh year and year ended on 31st March, 2026
  • Evoq Remedies - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday, 30Th May, 2026 And Intimation Un

    30 May 2026, 7:33PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Director
  • Evoq Remedies - Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 27Th May, 2026 To 30Th May, 20

    27 May 2026, 12:43PM Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and ap
  • Evoq Remedies has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    11 May 2026, 6:40PM As of March 2026, 0.02% is owned by Indian Promoters and 99.98% by Public. <p align=justify> Top Promoter holding highest number of shares of Evoq Rem
  • Evoq Remedies - Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 14Th May, 2026 To 27Th May, 20

    11 May 2026, 6:17PM Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and ap
  • Evoq Remedies - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 14Th May, 2026

    7 May 2026, 5:13PM Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and ap
  • Evoq Remedies - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    30 Apr 2026, 6:33PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Evoq Remedies - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2026, 7:13PM Compliances- Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Key fundamentals

Evaluate the intrinsic value of Evoq Remedies Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 44.3691 44.536 29.476 34.3617 31.3242
Liabilities 44.3691 44.536 29.476 34.3617 31.3242
Equity 24.9 24.9 13.6 13.6 13.6
Gross Profit -1.45 -2.2375 -1.6378 -3.733 1.4629
Net Profit -0.2399 0.0882 0.4524 1.6193 1.0912
Cash From Operating Activities -0.2819 -14.623 5.3198 -4.3457 -27.6377
NPM(%) -0.94 0.75 11.16 7.94 6.5
Revenue 25.5068 11.7567 4.0525 20.3899 16.7831
Expenses 26.9568 13.9942 5.6903 24.1229 15.3201
ROE(%) -0.54 0.19 1.02 3.65 2.46

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Evoq Remedies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 725.00 4.05 0.00 1.56 -26.19 0.69
Lotus Eye Hospital and Institute Ltd 133.50 -0.45 4503.33 5.68 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.01 1.13 0.00 11.79 -39.50 0.00
Astec Lifesciences Ltd 769.00 -0.20 0.00 5.35 -363.14 0.00

Company Info

Our Company was incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently the name of our company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 with certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad. Consequent upon the conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U24230GJ2010PLC059692.MAJOR EVENTS2010Incorporation of Company as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 19562021Conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad.

Our Company was incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently the name of our company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 with certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad. Consequent upon the conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U24230GJ2010PLC059692.MAJOR EVENTS2010Incorporation of Company as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 19562021Conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad.

Read More

Parent Organisation

Evoq Remedies Ltd.

Founded

24/02/2010

Managing Director

Mr.Bhumishth Patel

NSE Symbol

FAQ

The current price of Evoq Remedies Ltd is

The 52-week high for Evoq Remedies Ltd is

The market capitalization of Evoq Remedies Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Evoq Remedies Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Evoq Remedies Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Evoq Remedies Ltd shares.

The CEO of Evoq Remedies Ltd is Mr.Bhumishth Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT